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Overview: Toxoplasma gondii infection is
common in cats, but the clinical disease is rare.
Up to 50% of cats, especially free-roaming ones,
have antibodies indicating infection and the
presence of cystic stages. 
Disease signs: Clinical signs only appear in 
few cats when they become immunosuppressed
– in these situations cystic stages can be
reactivated. Commonly affected are the central
nervous system (CNS), muscles, lungs and eyes.
Human infection: Cats can pose a risk for
humans when they shed oocysts. However, 
this happens only once in their lifetime, usually
only for 3–10 days after ingestion of tissue cysts.
Thus, cats that have antibodies to T gondii no
longer shed oocysts, and do not pose a risk to
humans.
Agent properties
Toxoplasma gondii is an obligate intracellular coccidian parasite that can
infect virtually all species of warm-blooded animals, including people.
Domestic cats and other felids are the natural hosts – non-feline species
serve only as intermediates.1,2
Three infectious structures can be distinguished: sporozoites in
oocysts, tachyzoites (the actively multiplying stage), and bradyzoites
(the slowly multiplying stage) enclosed in tissue cysts. Oocysts are
excreted in faeces, whereas tachyzoites and bradyzoites are found in
tissues and milk.1,2 
Pathogenesis
Enteroepithelial life cycle
This cycle is found only in the feline host. Most cats are infected by
ingesting intermediate hosts – typically rodents – infected with tissue
cysts. Bradyzoites are released in the stomach and intestine from the
tissue cysts when digestive enzymes dissolve the cyst wall. They enter
epithelial cells of the small intestine and give rise to schizonts, initiate
five types of predetermined asexual stages, and merozoites released
from the schizonts eventually form male and female gamonts. After
fertilisation, a wall is formed around the fertilised macrogamont to
form an oocyst. Oocysts are round to oval, 10 x 12 μm in size, and are
still unsporulated
(not infectious)
when passed in fae-
ces. After exposure to
air and moisture for
1–5 days they sporu-
late to contain two
sporocysts, each with
four sporozoites.1,2
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, 
for the benefit of the health and welfare of cats. The
guidelines are based on current scientific knowledge of
the diseases and available vaccines concerned.
The latest version of the Toxoplasma gondii infection
in cats guidelines is available at www.abcd-vets.org
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The cycle is usually completed within 3–10
days of ingestion of tissue cysts, which is the
route of infection in up to 97% of naive cats. 
In the rare event that cats ingest oocysts or
tachyzoites, formation of new oocysts is
delayed and shedding can occur for up to 18
days (occasionally longer). However, only
20% of cats fed oocysts will shed.1,2
Extraintestinal life cycle 
The extraintestinal development of T gondii is
the same for all hosts, including cats, dogs,
and people, irrespective of whether tissue
cysts or oocysts have been ingested. After the
ingestion of oocysts, sporozoites hatch in the
lumen of the small intestine and enter intes-
tinal cells, including those in the lamina pro-
pria. Sporozoites divide into two by an
asexual process known as endodyogeny,
thereby becoming tachyzoites. These are
lunate (falciform) in shape, approximately 6 x
2 μm, and multiply in almost any cell of the
body. When the cell ruptures, releasing the
tachyzoites, these infect new cells. Otherwise,
tachyzoites multiply intracellularly for an
undetermined period, and eventually encyst.
Tissue cysts vary in size from 15–60 μm and
usually conform to the shape of the para-
sitised cell. Tissue cysts are formed mainly in
the CNS, muscles and visceral organs, and
probably persist for the life of the host. They
can be reactivated after immunosuppression,
which may then lead to clinical signs.1,2
Parasitaemia during pregnancy of the host
can cause placentitis and spread of tachy-
zoites to the fetus. Many kittens born to
queens infected with T gondii during gestation
become infected transplacentally or when
suckling. Clinical signs are common in these
kittens, varying with the stage of gestation at
the time of infection; some of these newborn
kittens shed oocysts.1,2
Epidemiology
Antibody prevalence to T gondii varies geo-
graphically: in Portugal, 24% of cats had anti-
bodies in one study;3 in the USA, 16–40% were
antibody-positive, depending on the state.2
However, only 3/326 faecal samples from cats in
California and 1/252 in Switzerland contained 
T gondii oocysts.4 The annual burden in the envi-
ronment is about 90–5000 oocysts per square
metre.5 The age of the cat does not play a role in
the frequency of T gondii shedding, but the sea-
son does: shedding is more common between
July and December in the northern hemisphere.6
The three major modes of transmission of 
T gondii in all host species are congenital infec-
tion, ingestion of infected tissue, and inges-
tion of oocyst-contaminated food or water.2
Less important are blood transfusions and
organ transplantations.1,2 Lactogenic transmis-
sion is suspected because the organism has
been detected in queen’s milk.7
T gondii blocks the innate aversion of rats for
cat urine, instead making them attracted by
the feline pheromone, which can increase the
likelihood of a cat capturing an infected rat.
This reflects adaptive ‘behavioural manipula-
tion’ by T gondii in optimising the chances of
completing the parasite’s life cycle: it repro-
duces only in the feline intestine. The behav-
ioural manipulation hypothesis postulates
that a parasite will specifically manipulate
host conduct essential for its transmission.
However, the neural circuits for innate fear,
anxiety and acquired fright all overlap, raising
the possibility that T gondii can disrupt all of
these non-specifically.8 Experimental infec-
tions have shown that T gondii can change
chemical messages in the CNS that affect
rodent behaviour because the infection can
lead to cyst formation in the CNS with pro-
duction of tyrosine hydroxylase, resulting in a
lack of dopamine.9–14
Meat contaminated with T gondii cysts has
been the primary source of infection in 
people, and antibody prevalence in humans 
is relatively high. Exposure from oocyst-
contaminated soil or water is common.
Indeed, water-borne outbreaks of toxoplasmo-
sis have been reported worldwide and support
the theory that exposure to environmental
oocysts poses a significant health risk.15
Clinical signs 
Clinical signs develop very rarely in infected
cats and are caused by inflammation and tissue
necrosis resulting from intracellular growth of
tachyzoites.2 Congenital infection tends to be
more serious than infection of the adult cat.2
Clinical toxoplasmosis develops during 
dissemination and intracellular replication of
tachyzoites. It usually originates from reactiva-
tion of a latent infection rather than after a
newly acquired infection. If a carrier cat is
immunosuppressed, bradyzoites in tissue
cysts replicate rapidly and disseminate again
as tachyzoites. Clinical toxoplasmosis has been
documented in some cats infected with feline
immunodeficiency virus (FIV) or feline
leukaemia virus (FeLV) [EBM grade III].16









The three major modes of transmission of 
T gondii in all host species are congenital infection,
ingestion of infected tissue, and ingestion of
oocyst-contaminated food or water.
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not predispose to reactivation of T gondii
cysts.17 However, administration of ciclosporin
to cats with renal transplants or dermatologi-
cal disease has been associated with clinical
manifestations [EBM grade IV].18–20
The most commonly affected tissues are the
CNS, muscles (Figure 1), lungs (Figure 2) and
eyes. Hepatic and pancreatic involvement is
less likely. Cats with toxoplasmosis show 
neurological signs (eg, seizures, ataxia), mus-
cle hyperaesthesia, dyspnoea, uveitis, icterus,
diarrhoea, fever, depression, anorexia and
weight loss.2 Transplacentally or lactogenically
infected kittens develop more severe signs and
frequently die of pulmonary or hepatic disease
[EBM grade III].21 Immune complex forma-
tion22 and deposition in tissues, as well as
delayed hypersensitivity reactions, can be
involved in chronic forms of toxoplasmosis.
Since T gondii is not cleared from the body,
either naturally or through treatment, toxo-
plasmosis can recur.
Immunity 
Immunity to T gondii in the cat is poorly under-
stood. In the mouse and in humans, it is highly
dependent on cell-mediated effector responses.23
All infected cats develop IgG and IgA anti-
bodies; about 80% also have IgM antibodies.
IgG can take 4–6 weeks to appear, and maxi-
mal antibody titres are achieved within 2–3
weeks of first appearance.2
Diagnosis 
Oocyst shedding is diagnosed by microscopy
of faecal samples. Diagnosis of the disease is
only confirmed when the organism is found in
body fluids or tissue. If suitable samples cannot
be taken, a tentative diagnosis is sometimes
based on rising IgM titres, exclusion of other
causes for the clinical signs, and a favourable
clinical response to anti-T gondii drugs [EBM
grade II].1,2
Figure 1 Myositis in a cat caused by T gondii cysts. The cat presented in lateral
recumbency, was unable to get up, and showed severe muscle hyperaesthesia.
Courtesy of Katrin Hartmann, Ludwig Maximilians University, Munich, Germany
Figure 2 Thoracic radiograph (laterolateral view) of a cat with pulmonary
toxoplasmosis. Courtesy of Katrin Hartmann, Ludwig Maximilians University, Munich,
Germany
Figure 3 Cytology of a 
fine-needle aspirate from 
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Detection of oocysts in faeces 
T gondii oocysts are 10 μm in size and best
demonstrated by centrifugation using
Sheather’s sugar solution (saccharose solution
with a specific gravity of 1.27 g/ml) during
the shedding period. T gondii oocysts are mor-
phologically indistinguishable from those of
Hammondia hammondi, Besnoitia oryctofelisi and
Besnoitia darlingi.2 A cesium chloride method
for easy purification of T gondii oocysts from
faeces of infected cats has been described.15
Detection of tachyzoites
Ante-mortem diagnosis of clinical toxoplas-
mosis ideally is based on the detection of the
organism by cytology or polymerase chain
reaction (PCR) [EBM grade III]. Tachyzoites
can be detected in various tissues and body
fluids during acute illness (Figure 3). They are
rarely found in blood, but occasionally in 
cerebrospinal fluid (CSF) or aqueous humour,
fine-needle aspirates of organs (eg, lymph
nodes), and transtracheal or bronchoalveolar
lavage fluid. Detection of tachyzoites results
in a definitive diagnosis. Alternatively, a PCR
can be performed using CSF, aqueous humour
or bronchoalveolar lavage fluid.
Detection of antibodies 
Using the immunofluorescence assay (IFA),
antibodies of the IgM, IgG and IgA isotypes
can be detected. For assessing human health
risks, antibody test results from healthy cats
are useful. An antibody-negative cat can be
shedding oocysts (early during infection,
before antibodies have had time to develop)
and will likely shed oocysts if exposed for the
first time. An antibody-positive cat does not
shed oocysts: antibodies need 2–3 weeks to
develop, by which time cats usually no longer
shed; and a cat sheds only once in its lifetime.
It is also unlikely to shed oocysts if re-exposed
or immunosuppressed [EBM grade II].1
Antibodies are commonly found in both
healthy and sick cats. Thus, their presence
does not prove clinical toxoplasmosis.
Antibodies of the IgM class are also common-
ly detected in healthy cats and do not corre-
late with clinical signs. 
Treatment 
Clindamycin is the treatment of choice24 and
should be administered at 10–12 mg/kg orally
q12h for 4 weeks (Table 1) [EBM grade III].
Cats with systemic disease and uveitis should
be treated with clindamycin in combination
with topical, oral or parenteral glucocorticoids,
to avoid secondary glaucoma and lens luxa-
tion [EBM grade III].25 Prednisolone acetate
(1% solution) applied topically to the eye three
to four times daily is generally sufficient. 
Clinical signs not involving the eyes or the
CNS usually begin to resolve within the first
2–3 days of clindamycin administration. CNS
and ocular toxoplasmosis tend to respond
more slowly. In cases of pulmonary toxo -
plasmosis, radiographic abnormalities might
not resolve  for several weeks. The prognosis
is usually poor in pulmonary or hepatic 
disease, particularly in immunocompromised
animals.26
Prevention of infection 
Preventing toxoplasmosis in cats involves
measures intended to reduce the incidence of
infections and the shedding of oocysts into the
environment. Cats should preferably be fed
commercially available, processed food.
Prevalence of feline T gondii infection is high-
er in countries where raw meat is fed.
Freezing or irradiation can kill tissue cysts
without affecting meat quality. Pets should be
prevented from hunting and eating intermedi-
ate hosts (rodents) or mechanical vectors, such
as cockroaches and earthworms. If meat is fed,
it should be thoroughly cooked, even if
frozen. Cats should be prevented from enter-
ing buildings where food-producing animals
are housed or where feed storage areas are
located.1
Drug Comment ABCD recommendation EBM grade
Antiparasitic therapy
Clindamycin 10–12 mg/kg PO q12h 
for 4 weeks (treatment of choice)
III
Symptomatic therapy
Prednisolone acetate (1%) For cats with Toxoplasma-
induced uveitis (to avoid
secondary glaucoma and 
lens luxation)
Use in addition to systemic antibiotic
treatment
Apply topically to the eye q6–8h
IV
Treatment of toxoplasmosisTable 1
Antibodies are commonly found in both 
healthy and sick cats. Thus, their presence 
does not prove clinical toxoplasmosis. 
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Public heath issues have come into focus (Box 1), partly because
of the increasing number of immunocompromised persons 
(eg, after infection with human immunodeficiency virus [HIV]). 
Also, recent research linking psychological and cognitive disorders
(eg, reduced IQ, as evidenced by psychomotor and verbal
intelligence tests) to T gondii infection have contributed. 
A recent survey among obstetricians and gynaecologists in 
the USA to determine their knowledge and practices relating to
toxoplasmosis prevention and testing found that most
overestimated the risk of cat ownership versus environmental risk
factors.27 A systematic review of risk factors for pregnant women
is available;28 it reports a relatively low risk associated with cat
ownership [EBM grade I]. 
Veterinarians commonly get questions from clients as to
whether or not to get rid of their cat during pregnancy. If hygiene
recommendations are followed (Boxes 2 and 3), the risk of 
transmission is low (Box 4).
Pub l i c  h e a l t h  c on s i d e r a t i o n s
Box 1 Routes of infection for humans
Common routes
< Ingestion of meat containing tissue cysts is the most
common route of infection. Thorough cooking or freezing
for several days will kill tissue cysts.29–32
< Ingestion of sporulated oocysts, either from the
environment (eg, through contact with contaminated soil)
or from faeces of shedding cats, is the second most
common route. This may also happen when eating
unwashed fruit or vegetables. Infection via the environment
is more common than direct infection through cat contacts.
Less common routes
< Ingestion of sporulated oocysts through contact with
contaminated water.
< Ingestion of raw (unpasteurised) goat’s milk.
< Inhalation of sporulated oocysts on dust particles (rare).
Box 2 Recommendations to reduce the risk
of parasite transmission from cat to owner
< Litter trays should be emptied daily so that oocysts do not
have sufficient time (24 h) to sporulate.
< Gloves should be worn when handling cat litter, and hands
should be washed thoroughly after cleaning of litter trays.
< Litter tray liners should be used, if possible, and the tray
cleaned regularly with detergent and scalding water.
< Cat litter should be disposed in sealed plastic bags.
< Children’s sandpits should be covered when not in use, to
prevent cats from using them.
< Only properly cooked food or commercial cat food should
be fed.
< Hands should be washed after contact with a cat
(especially before eating).
Box 4 Evidence that contact with cats does
not increase the risk ofT gondii infection33 
< Cats shedding oocysts in faeces are rare.34 In one
study, only about 1/250 cats shed oocysts.4
< Contact with cats has no influence on the probability of
people developing antibodies to T gondii, whereas the
consumption of raw meat significantly increases the risk 
of acquiring the infection.35
< Veterinarians working with cats are not more likely to
become infected with T gondii or to suffer from
toxoplasmosis than the general population, including
people without cat contacts.36–38
< Stroking a cat will not spread the infection. Even when cats
are shedding oocysts in their faeces, oocysts cannot be
found on their coat.39 Studies in dogs have shown that
oocysts do not sporulate on their fur, and the same is
probably true for cats.40
< Cat ownership does not increase the risk of toxoplasmosis
in people with HIV infection. Although toxoplasmosis is
more common in HIV-infected persons, the disease results
from reactivation of a previous infection rather than from
acquiring a new infection.
< Most people are infected with T gondii through ingestion of
undercooked meat, especially goat, mutton and pork. The
risk of infection from cats is low, except for young children
playing in soil contaminated with sporulated oocysts.41
< Bites or scratches from an infected cat do not transmit the
infection.
< Infected cats under treatment with immunosuppressive
drugs at standard doses do not start shedding oocysts in
their faeces.17
< Infected cats also do not re-shed oocysts in their faeces
when they become immunosuppressed due to infection
with FIV or FeLV.42 Cats infected with FIV or FeLV that are
subsequently infected with T gondii do not shed oocysts
for any longer or in any greater numbers than other cats.2,43
< Newly identified strains of T gondii are highly infectious for
species other than cats; thus, cats might actually become
less important in the spread of this infection.
Box 3 Additional advice for households
with immunocompromised persons or
pregnant women
< Immunosuppressed persons and pregnant women should
avoid contact with cat litter.
< Cats should be kept indoors to prevent them hunting 
and eating intermediate hosts such as voles and mice.
< Cats should not be fed raw or partially cooked meat.
< Cats should be discouraged from eating insects 
(eg, cockroaches).
< Cats should be tested for T gondii antibodies; their
presence indicates past infection. These cats will not be 
a source of infection as they have completed their period 
of oocyst shedding.
< Cats without antibody will have not been infected
previously and, when newly infected, will shed oocysts 
in their faeces for a short time. They should, therefore, 
be kept indoors during the phase of immunosuppression 
or pregnancy of the owner.
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< T gondii infection is common in cats. The clinical picture
toxoplasmosis, however, is rare.
< Up to 50% of cats have antibodies, which show they are infected
and harbour T gondii cysts.
< Clinical signs usually occur when cats become immunosuppressed,
due to the reactivation of cystic stages.
< Commonly affected sites are the CNS, muscles, lungs and eyes. 
< Cats shedding oocysts can pose a risk to humans. However, they
shed only once in their lifetime, and usually for only 3–10 days
after ingestion of tissue cysts.
< Cats with T gondii antibodies no longer shed oocysts; they
neither are nor will become a zoonotic risk.
< A definitive diagnosis of toxoplasmosis relies on the detection 
of the organism in body fluids or tissues.
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